|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2022
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/21100
Title: | Outcome prediction of anti-vegf therapy in age-related macular degeneration |
Authors: | Bobescu, Nicolae |
Keywords: | age-related macular degeneration;anti-VEGF;predictive factors |
Issue Date: | 2022 |
Publisher: | Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, Association of Medical Students and Residents |
Citation: | BOBESCU, Nicolae. Outcome prediction of anti-vegf therapy in age-related macular degeneration. In: MedEspera: the 9th International Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2022, p. 293. |
Abstract: | Introduction. Age-related macular degeneration (AMD) is one of the leading causes of irreversible
blindness in adults over 50 years old. At present it has no cure. In advanced AMD stages, the patient has
no ability to perform basic activities such as reading, recognizing faces, and driving. The global prevalence
of AMD is expected to increase to 288 million by 2040. This review article comes with useful information
on the anti-VEGF effects in various clinical situations, bringing real benefit to the clinical activity. It aims
to study the factors that predict the evolution of AMD in order to understand the therapy response.
Aim of study. Age- related macular degeneration is a very frequent, acquired retinal pathology that causes
loss of central vision. There are specific therapeutic methods used in each stage of the pathology. In contrast
to the atrophic (dry) form, exudative (wet) form of AMD requires inhibitors of the vascular endothelial
growth factor (anti-VEGF remedies). Treatment is applied in some specific patterns. The analysis of the
factors involved in the variability of the pathological process response to anti-VEGF treatment allows the
development of an algorithm for stratification of patients with AMD.
Methods and materials. PubMed, NCBI and SCOPUS databases were used to find relevant information
on the topic, using the next keywords: age-related macular degeneration, anti-VEGF, predictive factors.
We studied 50 of 175 articles.
Results. AMD outcome depends on age, sex, genetics, environmental, clinical and social factors. This
important clinical factors could help us to give some prognosis about disease evolution under treatment.
Very often, the clinician can predict from the beginning what the subsequent evolution of the pathology
will be.
Conclusion. The analysis of the factors involved in the variability of the pathological process response to
anti-VEGF treatment allows the development of an algorithm for stratification of patients with age-related
macular degeneration. |
metadata.dc.relation.ispartof: | MedEspera: The 9th International Medical Congress for Students and Young Doctors, May 12-14, 2022, Chisinau, Republic of Moldova |
URI: | https://medespera.asr.md/en/books http://repository.usmf.md/handle/20.500.12710/21100 |
Appears in Collections: | MedEspera 2022
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|